Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic

Abstract

Highly pathogenic avian H5N1 influenza A virus has caused influenza outbreaks in poultry and migratory birds in Southeast Asia, Africa and Europe, and there is concern that it could cause a new pandemic. This fear of an emerging pandemic of a new influenza strain underscores the urgency of preparing effective vaccines to meet the pandemic. One way to mitigate current concerns is to develop an influenza vaccine that is fully functional against drift influenza viruses. In our current situation, in which we cannot predict which strain will cause a pandemic, cross-protective immunity using potential and novel mucosal vaccines plays a particularly important role in preventing the spread of highly pathogenic influenza virus.

Keywords::

• adjuvant
• cross protection
• highly pathogenic avian influenza
• mucosal immunity
• nasal vaccine
• secretory immunoglobulin A

Acknowledgements

The authors wish to express appreciation to all participants whose works are cited in this review.